We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
Cap. Flow
+$3.18B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.93B
2
MSFT icon
Microsoft
MSFT
+$556M
3
COR icon
Cencora
COR
+$492M
4
NFLX icon
Netflix
NFLX
+$452M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Consumer Discretionary 12.64%
3 Healthcare 9.35%
4 Financials 8.34%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELO icon
3476
Telomir Pharmaceuticals
TELO
$79.1M
-75,770
Closed -$94.7K
TBRG
3477
DELISTED
TruBridge
TBRG
-24,619
Closed -$577K
QTTB icon
3478
Q32 Bio
QTTB
$450M
-16,928
Closed -$25.2K
CTRI icon
3479
Centuri Holdings
CTRI
$2.79B
-290,598
Closed -$6.52M
VIK icon
3480
Viking Holdings
VIK
$44.9B
-386,197
Closed -$20.6M
ZK
3481
DELISTED
Zeekr
ZK
-67,497
Closed -$1.72M
OKLO
3482
Oklo
OKLO
$7B
-36,010
Closed -$2.02M
CHA
3483
Chagee Holdings Ltd
CHA
$2.14B
-527,151
Closed -$13.8M
LB
3484
LandBridge Co
LB
$2.12B
-27,932
Closed -$1.89M
ATYR
3485
aTyr Pharma
ATYR
$46.4M
-511,412
Closed -$2.59M
TWFG
3486
TWFG Inc
TWFG
$342M
-128,682
Closed -$4.5M
ARTV
3487
Artiva Biotherapeutics
ARTV
$487M
-52,213
Closed -$78.8K
CON
3488
Concentra Group Holdings
CON
$4.04B
-182,857
Closed -$3.76M
LINE
3489
Lineage Inc
LINE
$9.43B
-35,366
Closed -$1.54M
SEG
3490
Seaport Entertainment Group
SEG
$333M
-23,754
Closed -$443K
UCB
3491
United Community Banks
UCB
$4.22B
-7,748
Closed -$231K
BGM
3492
BGM Group Ltd
BGM
$116M
-20,632
Closed -$218K
AMTM
3493
Amentum Holdings
AMTM
$5.51B
-74,831
Closed -$1.77M
HURA
3494
TuHURA Biosciences
HURA
$134M
-35,571
Closed -$79.3K
PRMB
3495
Primo Brands
PRMB
$8.24B
-213,363
Closed -$6.32M
CNCK
3496
Coincheck Group
CNCK
$522M
-35,120
Closed -$192K
PVLA
3497
Palvella Therapeutics
PVLA
$1.98B
-49,077
Closed -$1.11M
AAMI
3498
Acadian Asset Management
AAMI
$2.88B
-13,316
Closed -$469K
CEPO
3499
Cantor Equity Partners I
CEPO
$272M
-80,092
Closed -$953K
TTAM
3500
Titan America SA
TTAM
$3.16B
-55,547
Closed -$693K

Similar funds

Marshall Wace's Q3 2025 Portfolio in Review

As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.

  • Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
  • Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
  • Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
  • Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
  • Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.